磁共振弹性成像测量的肝脏硬度可预测非酒精性脂肪性肝病未来肝硬化、失代偿和死亡
研究纳入2007至2019年在Mayo Clinic Rochester接受MRE的829例NAFLD成人,评估基线LSM对非肝硬化者未来肝硬化及代偿期肝硬化者失代偿或死亡的预测作用。基线LSM可预测未来肝硬化(年龄校正HR=2.93每1 kPa,C统计量=0.86)及失代偿或死亡(校正后HR=1.32每1 kPa)。
要点
- 非肝硬化NAFLD中,基线LSM每增加1 kPa,未来肝硬化风险年龄校正HR=2.93。
- 代偿期肝硬化中,基线LSM每增加1 kPa,失代偿或死亡风险校正后HR=1.32。
- 基线LSM为2、3、4-5 kPa时,可分别指导5、3、1年的无创监测间隔。
核心结论
- 在NAFLD中,MRE测量的LSM是未来肝硬化发生的显著预测因素。
- 这些数据拓展了MRE在临床实践中的作用,不仅限于评估肝纤维化,并为个体化疾病监测和患者咨询提供了重要证据。
研究设计与样本
- 研究纳入2007年至2019年在Mayo Clinic Rochester接受MRE的NAFLD成人,共829例(54%女性,中位年龄58岁)。
- 采用Cox回归分析基线LSM对非肝硬化NAFLD发生肝硬化、以及代偿期肝硬化发生失代偿或死亡的预测作用。
主要发现
- 639例无肝硬化受试者中,中位随访4年后20例发生肝硬化;基线LSM预测未来肝硬化,年龄校正HR=2.93(95%CI 1.86-4.62,p<.0001)每1 kPa增量,C统计量=0.86。
- 194例代偿期肝硬化受试者中,中位随访5年后81例发生失代偿或死亡;基线LSM预测失代偿或死亡,校正年龄、性别和MELD-Na后HR=1.32(95%CI 1.13-1.56,p=.0007)每1 kPa增量。
- 基线LSM为5 kPa vs 8 kPa的肝硬化患者,1年未来失代偿或死亡概率分别为9% vs 20%。
关键数值与推荐
- 基线LSM为2、3、4-5 kPa时,分别可指导5、3、1年的纵向无创监测间隔。
临床怎么用
- 基线LSM by MRE可用于指导纵向无创监测的时间安排:LSM为2、3、4-5 kPa分别对应5、3、1年监测间隔。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Magnetic resonance elastography (MRE) is the most accurate method of liver stiffness measurement (LSM) in nonalcoholic fatty liver disease (NAFLD). We aimed to investigate the role of MRE in the prediction of hard outcomes in NAFLD. METHODS AND RESULTS: Adults with NAFLD who underwent MRE between 2007 and 2019 at Mayo Clinic, Rochester were identified. Cox regression analyses were used to explore the predictive role of baseline LSM for 1) development of cirrhosis in noncirrhotic NAFLD and 2) development of liver decompensation or death in those with compensated cirrhosis. A total of 829 NAFLD subjects (54% women, median age 58 years) were identified. Of 639 subjects without cirrhosis, 20 developed cirrhosis after a median follow-up of 4 years. Baseline LSM was predictive of future cirrhosis development: age-adjusted HR = 2.93 (95% CI, 1.86-4.62, p <.0001) per 1 kPa increment (C-statistic = 0.86). Baseline LSM by MRE can be used to guide timing of longitudinal noninvasive monitoring: 5, 3 and 1 years for LSM of 2, 3 and 4-5 kPa, respectively. Of 194 subjects with compensated cirrhosis, 81 developed decompensation or death after a median follow-up of 5 years. Baseline LSM was predictive of future decompensation or death: HR = 1.32 (95% CI, 1.13-1.56, p = .0007) per 1 kPa increment after adjusting for age, sex and MELD-Na. The 1-year probability of future decompensation or death in cirrhosis with baseline LSM of 5 kPa vs 8 kPa is 9% vs 20%, respectively. CONCLUSION: In NAFLD, LSM by MRE is a significant predictor of future development of cirrhosis. These data expand the role of MRE in clinical practice beyond the estimation of liver fibrosis and provide important evidence that improves individualized disease monitoring and patient counseling.
引用
- Gidener T, Ahmed OT, Larson JJ, et al. Liver Stiffness by Magnetic Resonance Elastography Predicts Future Cirrhosis, Decompensation, and Death in NAFLD. Clin Gastroenterol Hepatol. 2020. PMID: 33010409. doi:10.1016/j.cgh.2020.09.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。